MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 130 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $130,000 | -35.6% | 31,920 | 0.0% | 0.00% | – |
| Q3 2016 | $202,000 | +2.5% | 31,920 | -12.6% | 0.00% | – |
| Q2 2016 | $197,000 | -35.6% | 36,522 | -0.6% | 0.00% | – |
| Q1 2016 | $306,000 | +5.2% | 36,725 | +0.1% | 0.00% | – |
| Q4 2015 | $291,000 | +24.9% | 36,703 | +34.4% | 0.00% | – |
| Q3 2015 | $233,000 | -7.2% | 27,303 | +34.2% | 0.00% | – |
| Q2 2015 | $251,000 | +5.5% | 20,343 | +1.2% | 0.00% | – |
| Q1 2015 | $238,000 | +5850.0% | 20,105 | +5727.5% | 0.00% | – |
| Q4 2014 | $4,000 | -92.9% | 345 | -97.7% | 0.00% | – |
| Q3 2013 | $56,000 | -44.0% | 14,780 | 0.0% | 0.00% | – |
| Q2 2013 | $100,000 | – | 14,780 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
| Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
| Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
| INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
| GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
| Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
| Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |